Gangliosides of the Vertebrate Nervous System

Research output: Contribution to journalReview article

Abstract

Gangliosides, sialylated glycosphingolipids, found on all vertebrate cells and tissues, are major molecular determinants on the surfaces of vertebrate nerve cells. Composed of a sialylated glycan attached to a ceramide lipid, the same four structures—GM1, GD1a, GD1b, and GT1b—represent the vast majority (> 90%) of gangliosides in the brains of all mammals and birds. Primarily found on the outer surface of the plasma membrane with their glycans facing outward, gangliosides associate laterally with each other, sphingomyelin, cholesterol, and select proteins in lipid rafts—the dynamic functional subdomains of the plasma membrane. The functions of gangliosides in the human nervous system are revealed by congenital mutations in ganglioside biosynthetic genes. Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits. The molecular functions of brain gangliosides include regulation of receptors in the same membrane via lateral (cis) associations and regulation of cell–cell recognition by trans interaction with ganglioside binding proteins on apposing cells. Gangliosides also affect the aggregation of Aβ (Alzheimer's disease) and α-synuclein (Parkinson's Disease). As analytical, biochemical, and genetic tools advance, research on gangliosides promises to reveal mechanisms of molecular control related to nerve and glial cell differentiation, neuronal excitability, axon outgrowth after nervous system injury, and protein folding in neurodegenerative diseases.

Original languageEnglish (US)
Pages (from-to)3325-3336
Number of pages12
JournalJournal of Molecular Biology
Volume428
Issue number16
DOIs
StatePublished - Aug 14 2016

Fingerprint

Gangliosides
Nervous System
Vertebrates
Mutation
Polysaccharides
Brain
Synucleins
Hereditary Spastic Paraplegia
Cell Membrane
Nervous System Trauma
Lipids
Neurons
Glycosphingolipids
Sphingomyelins
Ceramides
Protein Folding
Neuroglia
Neurodegenerative Diseases
Genes
Birds

Keywords

  • glycan binding protein
  • glycosphingolipid
  • lipid raft
  • receptor tyrosine kinase
  • sialic acid

ASJC Scopus subject areas

  • Medicine(all)
  • Molecular Biology

Cite this

Gangliosides of the Vertebrate Nervous System. / Schnaar, Ronald Lee.

In: Journal of Molecular Biology, Vol. 428, No. 16, 14.08.2016, p. 3325-3336.

Research output: Contribution to journalReview article

@article{adcc4fae10d547268dccdd17298dbc80,
title = "Gangliosides of the Vertebrate Nervous System",
abstract = "Gangliosides, sialylated glycosphingolipids, found on all vertebrate cells and tissues, are major molecular determinants on the surfaces of vertebrate nerve cells. Composed of a sialylated glycan attached to a ceramide lipid, the same four structures—GM1, GD1a, GD1b, and GT1b—represent the vast majority (> 90{\%}) of gangliosides in the brains of all mammals and birds. Primarily found on the outer surface of the plasma membrane with their glycans facing outward, gangliosides associate laterally with each other, sphingomyelin, cholesterol, and select proteins in lipid rafts—the dynamic functional subdomains of the plasma membrane. The functions of gangliosides in the human nervous system are revealed by congenital mutations in ganglioside biosynthetic genes. Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits. The molecular functions of brain gangliosides include regulation of receptors in the same membrane via lateral (cis) associations and regulation of cell–cell recognition by trans interaction with ganglioside binding proteins on apposing cells. Gangliosides also affect the aggregation of Aβ (Alzheimer's disease) and α-synuclein (Parkinson's Disease). As analytical, biochemical, and genetic tools advance, research on gangliosides promises to reveal mechanisms of molecular control related to nerve and glial cell differentiation, neuronal excitability, axon outgrowth after nervous system injury, and protein folding in neurodegenerative diseases.",
keywords = "glycan binding protein, glycosphingolipid, lipid raft, receptor tyrosine kinase, sialic acid",
author = "Schnaar, {Ronald Lee}",
year = "2016",
month = "8",
day = "14",
doi = "10.1016/j.jmb.2016.05.020",
language = "English (US)",
volume = "428",
pages = "3325--3336",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "16",

}

TY - JOUR

T1 - Gangliosides of the Vertebrate Nervous System

AU - Schnaar, Ronald Lee

PY - 2016/8/14

Y1 - 2016/8/14

N2 - Gangliosides, sialylated glycosphingolipids, found on all vertebrate cells and tissues, are major molecular determinants on the surfaces of vertebrate nerve cells. Composed of a sialylated glycan attached to a ceramide lipid, the same four structures—GM1, GD1a, GD1b, and GT1b—represent the vast majority (> 90%) of gangliosides in the brains of all mammals and birds. Primarily found on the outer surface of the plasma membrane with their glycans facing outward, gangliosides associate laterally with each other, sphingomyelin, cholesterol, and select proteins in lipid rafts—the dynamic functional subdomains of the plasma membrane. The functions of gangliosides in the human nervous system are revealed by congenital mutations in ganglioside biosynthetic genes. Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits. The molecular functions of brain gangliosides include regulation of receptors in the same membrane via lateral (cis) associations and regulation of cell–cell recognition by trans interaction with ganglioside binding proteins on apposing cells. Gangliosides also affect the aggregation of Aβ (Alzheimer's disease) and α-synuclein (Parkinson's Disease). As analytical, biochemical, and genetic tools advance, research on gangliosides promises to reveal mechanisms of molecular control related to nerve and glial cell differentiation, neuronal excitability, axon outgrowth after nervous system injury, and protein folding in neurodegenerative diseases.

AB - Gangliosides, sialylated glycosphingolipids, found on all vertebrate cells and tissues, are major molecular determinants on the surfaces of vertebrate nerve cells. Composed of a sialylated glycan attached to a ceramide lipid, the same four structures—GM1, GD1a, GD1b, and GT1b—represent the vast majority (> 90%) of gangliosides in the brains of all mammals and birds. Primarily found on the outer surface of the plasma membrane with their glycans facing outward, gangliosides associate laterally with each other, sphingomyelin, cholesterol, and select proteins in lipid rafts—the dynamic functional subdomains of the plasma membrane. The functions of gangliosides in the human nervous system are revealed by congenital mutations in ganglioside biosynthetic genes. Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits. The molecular functions of brain gangliosides include regulation of receptors in the same membrane via lateral (cis) associations and regulation of cell–cell recognition by trans interaction with ganglioside binding proteins on apposing cells. Gangliosides also affect the aggregation of Aβ (Alzheimer's disease) and α-synuclein (Parkinson's Disease). As analytical, biochemical, and genetic tools advance, research on gangliosides promises to reveal mechanisms of molecular control related to nerve and glial cell differentiation, neuronal excitability, axon outgrowth after nervous system injury, and protein folding in neurodegenerative diseases.

KW - glycan binding protein

KW - glycosphingolipid

KW - lipid raft

KW - receptor tyrosine kinase

KW - sialic acid

UR - http://www.scopus.com/inward/record.url?scp=84982062283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982062283&partnerID=8YFLogxK

U2 - 10.1016/j.jmb.2016.05.020

DO - 10.1016/j.jmb.2016.05.020

M3 - Review article

VL - 428

SP - 3325

EP - 3336

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 16

ER -